financetom
Market
financetom
/
Market
/
Currently overweight on cement and underweight on financials: Valentis’ Jyotivardhan Jaipuria
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Currently overweight on cement and underweight on financials: Valentis’ Jyotivardhan Jaipuria
Apr 1, 2021 6:06 AM

Jyotivardhan Jaipuria, Founder & MD of Valentis Advisors spoke to CNBC-TV18 to discuss the fundamentals of the market. Jaipuria said that he has been more bullish on economy plays in the last 6 months. However, he sees a bit of correction in those stocks in the near term.

Share Market Live

NSE

He further said that he prefers financials, especially private banks, and will invest in those once their valuation comes down.

“We have reduced our weightage on banks even more so we are now substantially underweight financials but that is more like a very practical thing because I think we will get this cheaper and I want to buy them once we see that correction coming through,” he explained.

He also likes cement and auto ancillaries.

"We think that over the next few weeks if you look at very tactically you could see pharma coming back and pharma starting to do a little better performance relative to the market," he added.

Watch video for more.

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.

(Edited by : Pranati Deva)

First Published:Apr 1, 2021 3:06 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Pharma sector buzzing in trade; details here
Pharma sector buzzing in trade; details here
Mar 11, 2022
The Nifty Pharma Index is up 2 percent, it is at the high point of the day. Stocks like Cipla and Sun Pharma have outperformed the market. Overall it is defensive buying, if you look at it on a week-to-date basis as well as a month-to-date basis, the Nifty Pharma Index has outperformed the market. It might not be on a year-to-date basis but if you look at it, month-to-date, the Nifty Pharma Index is up around 2.8 percent. Nifty is just about down around 0.9 percent.
Government to file final papers for LIC IPO with Sebi soon
Government to file final papers for LIC IPO with Sebi soon
Mar 11, 2022
"We have got the approval of the DRHP and the next step would be to file the RHP, which will give details of the price band and the actual number of shares. We are watching the situation, and soon we will take a call on the timing of the share sale," an official told PTI.
Stock Market Highlights: Sensex ends volatile session 86 pts higher, Nifty50 tops 16,600; Sun Pharma up 4%, DRL 2%
Stock Market Highlights: Sensex ends volatile session 86 pts higher, Nifty50 tops 16,600; Sun Pharma up 4%, DRL 2%
Mar 10, 2022
Stock Market Highlights: Indian equity benchmarks Sensex and Nifty50 managed to close higher for a fourth straight day on Friday but lost steam. Gains in pharma stocks were offset by losses in select auto counters. Among heavyweights, strength in ITC and HDFC Bank kept the headline indices in the green, but losses in TCS and Maruti Suzuki limited the upside. Globally, investors turned cautious after a 40-year high reading in US consumer inflation fueling fears of aggressive hikes in pandemic-era interest rates. Nervousness also persisted among investors over the Russia-Ukraine war.
Rupee pares initial gains, settles 18 paise lower at 76.61 against US dollar
Rupee pares initial gains, settles 18 paise lower at 76.61 against US dollar
Mar 11, 2022
At the interbank foreign exchange market, the rupee opened weak at 76.34 against the American dollar and fell further during the session as investors moved away from riskier assets. The domestic unit oscillated between a high of 76.27 and a low of 76.72 during the session. The rupee finally settled at 76.61 against the dollar, down 18 paise from the previous close.
Copyright 2023-2026 - www.financetom.com All Rights Reserved